...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >1-(5-Carboxyindol-1-yl)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: synthesis and properties of bioisosteric benzimidazole, benzotriazole and indazole analogues.
【24h】

1-(5-Carboxyindol-1-yl)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: synthesis and properties of bioisosteric benzimidazole, benzotriazole and indazole analogues.

机译:1-(5-羧吲哚-1-基)Propan-2-作为人细胞源磷脂酶A2Alpha的抑制剂:Bioisoster苯并咪唑,苯并三唑和吲唑类似物的合成和性能。

获取原文
获取原文并翻译 | 示例
           

摘要

The indole ring systems of the cytosolic phospholipase A(2)alpha (cPLA(2)alpha) inhibitor 1-[3-(4-octylphenoxy)-2-oxopropyl]indole-5-carboxylic acid (2) and the isomeric 6-carboxylic acid (3) were replaced by benzimidazole, benzotriazole and indazole scaffolds, respectively. The effect of the structural variations on cPLA(2)alpha inhibitory potency, metabolic stability and solubility was studied. The lead 2 and the indazole-5-carboxylic acid 28 were the metabolically most stable compounds in an assay with rat liver microsomes, while the benzimidazole-5-carboxylic acid derivative 13 possessed the best water solubility (22 microg/mL at pH 7.4). The indazole-5-carboxylic acid 28 revealed the highest cPLA(2)alpha inhibitory potency of the compounds in this series. With an IC(50)-value of 0.005 microM it was about sevenfold more active than the lead 2.
机译:细胞骨磷脂酶A(2)α(CPLA(2)α)抑制剂1- [3-(4-(4-辛基苯氧基)-2-氧丙酸]吲哚-5-羧酸(2)和异构6- 羧酸(3)分别用苯并咪唑,苯并三唑和吲唑支架代替。 研究了结构变异对CPLA(2)α抑制效力,代谢稳定性和溶解度的影响。 引线2和吲唑-5-羧酸28是具有大鼠肝微粒体的测定中的代谢最稳定的化合物,而苯并咪唑-5-羧酸衍生物13具有最佳的水溶性(22微孔/ mL在pH7.4时) 。 吲唑-5-羧酸28揭示了该系列中化合物的最高CPLA(2)α抑制效力。 对于IC(50) - 0.005 microm的值大约是七倍比引线2更活跃。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号